Catalog Number UNK_THERMOCOOL SF NON NAV |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problems
Nerve Damage (1979); Cardiac Tamponade (2226); Pseudoaneurysm (2605)
|
Event Date 07/26/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
This complaint is from a literature source.The following literature cite has been reviewed: ukita k, egami y, kawamura a, nakamura h, matsuhiro y, yasumoto k, tsuda m, okamoto n, matsunaga-lee y, yano m, nishino m, tanouchi j.Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.J cardiol.2021 aug 20:s0914-5087(21)00199-4.Doi: 10.1016/j.Jjcc.2021.08.004.Epub ahead of print.Pmid: 34426045.No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer¿s reference number: (b)(4).
|
|
Event Description
|
This complaint is from a literature source.The following literature cite has been reviewed: ukita k, egami y, kawamura a, nakamura h, matsuhiro y, yasumoto k, tsuda m, okamoto n, matsunaga-lee y, yano m, nishino m, tanouchi j.Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.J cardiol.2021 aug 20:s0914-5087(21)00199-4.Doi: 10.1016/j.Jjcc.2021.08.004.Epub ahead of print.Pmid: 34426045.Objective: ¿the aim of this study was to elucidate the characteristics and significance of very early recurrence of af (veraf) after rfca.¿ methods/study data: ¿a total of 610 patients underwent an initial rfca of af between september 2014 and april 2019 in our hospital.Among them, 201 patients experienced eraf (defined as recurrence of af within 3 months after rfca).These patients were categorized into three groups: group a who experienced recurrence of atrial tachyarrhythmia only within 48 h after rfca, group b who experienced recurrence of atrial tachyarrhythmia both within 48 h and between 48 h and 3 months after rfca, and group c who experienced the first recurrence of atrial tachyarrhythmia between 48 h and 3 months after rfca.¿ lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: thermocool smarttouchtm (biosense webster) other biosense webster devices that were also used in this study: carto3 (biosense webster).Pentaray (biosense webster).Non-biosense webster devices that were also used in this study: duodecapolar catheter (beeat).8.5fr sl0 (st jude medical).Adverse event(s) and provided interventions: (3) cardiac tamponade.(6) phrenic nerve injury.(4) femoral pseudoaneurysm.Treatments relating to adverse events nor outcomes were provided within the article.
|
|
Search Alerts/Recalls
|
|